Pediatrics
Cow’s milk protein allergy (CMPA)
Timing after milk exposure helps distinguish an immediate IgE reaction from delayed gut symptoms. The diagnosis then depends on the history and an appropriate confirmation plan.
Covered only in other uploaded question sources · 0 main-bank entries · 25 linked PDF entries · 4 generated drills
Prerequisites and related lessons
- Gastroesophageal reflux disease (GERD)
- Lower GIT bleeding
Curriculum reference · Official College Textbook – Digestive Disorders – Part 1, pp. 267–269. Lesson adapted from Allergy, bleeding and cystic fibrosis.
Topic map
- Milk proteinscasein and β-lactoglobulin
- Immediate IgEhives, wheeze, vomiting, anaphylaxis
- Delayed non-IgEproctocolitis, enteropathy, FPIES
- Confirmappropriate elimination and challenge or reintroduction
Scroll the diagram to see all labels.
Definition, timing and epidemiology
Cow’s milk protein allergy is an immune-mediated reaction to milk proteins [Pediatric Mid Q1/Q7], including casein and β-lactoglobulin [Pediatric Mid Q2/Q7]. Lactose intolerance is impaired digestion of a sugar, leading to gas, cramps and osmotic watery diarrhea. Lactose-free cow’s milk formula can still contain allergenic proteins. Ruminant milks share related proteins, so ordinary goat or sheep milk is unsuitable as an allergy substitute. CMPA commonly begins in the first year. Book I quotes about 3% of infants and uncommon persistence after age five, with rates varying by population and diagnostic criteria.
Clinical phenotypes
IgE-mediated allergy appears within minutes to about two hours [Pediatric Mid Q4 · Old p. 39 Q10]. Features include urticaria, angioedema, vomiting, wheeze, stridor or circulatory collapse. Skin and breathing symptoms soon after a feed favor it over delayed FPIES. Acute suspected anaphylaxis requires emergency treatment with intramuscular epinephrine. Atopic eczema, asthma or family allergy history can support context without establishing the diagnosis.
Non-IgE reactions are delayed [Pediatric Mid Q5–6], with symptoms hours to days or longer. Food protein-induced allergic proctocolitis (FPIAP) can give blood-streaked mucus in a generally well young infant [IRAT Q19 · Old p. 52 Q10]. Food protein-induced enteropathy can cause persistent diarrhea, malabsorption and growth faltering. Acute food protein-induced enterocolitis syndrome (FPIES) classically causes repetitive vomiting 1–4 hours after ingestion, with pallor and lethargy, and sometimes later diarrhea or shock. Immediate hives/wheeze are not typical of FPIES. Mixed mechanisms can occur, including in some atopic or eosinophilic disorders. Underfeeding, fever, abdominal distension, severe lethargy, bilious vomiting or ongoing significant bleeding broaden the differential and urgency.
Evaluation and diagnostic confirmation
- Initial assessment
- Allergy-focused history and growth assessment
- Confirmation or next test
- Short elimination followed by appropriate reintroduction or supervised challenge. Milk-specific IgE supports an immediate phenotype.
Take a focused history: feed details, timing, reproducibility, symptoms across systems, severity, growth and other explanations. The Cow’s Milk Related Symptom Score (CoMiSS) [Pediatric Mid Q8–10 · Formative Q3] is an awareness tool. In the textbook, ≥10 raises suspicion and <6 suggests looking for other causes. Scores neither prove allergy nor identify an IgE mechanism. The Pediatric Mid Q8 key for a score of 12 conflicts with the textbook; the “may suggest” option is supported.
Milk-specific serum IgE and skin prick testing [Pediatric Mid Q11] can support an immediate phenotype. A positive result shows sensitization and must be correlated with symptoms. Negative IgE tests do not exclude delayed allergy. Total IgE and occult blood alone do not confirm CMPA. A short diagnostic elimination followed by planned reintroduction or supervised oral food challenge [Old p. 52 Q10 · Book I pp. 267–269] distinguishes improvement with removal from a reproducible reaction. Non-IgE elimination is often 2–4 weeks. Timing, setting and whether to challenge depend on prior severity and specialist assessment. Do not attempt home challenge after an immediate severe reaction or suspected FPIES without specialist direction.
Feeding and treatment
Support breastfeeding. The course lists immunoglobulin A, lactoferrin, antimicrobial peptides, hormones and human milk oligosaccharides as bioactive components. Most breastfed infants do not need maternal restriction. If the history supports allergy during exclusive breastfeeding, use a time-limited maternal cow’s milk protein exclusion with dietetic advice and planned confirmation. If restriction continues, consider calcium, vitamin D and dietary adequacy. Preserving nutrition and avoiding unnecessary additional food exclusions matter.
For most formula-fed infants with confirmed CMPA, use extensively hydrolyzed formula (eHF) with proven efficacy [Pediatric Mid Q12 · Formative Q4 · IRAT Q13/Q19]. Extensive hydrolysis reduces protein into smaller peptides. Partially hydrolyzed formula is unsuitable for treatment. Amino acid-based formula (AAF) [Pediatric Mid Q13–14 · Formative Q4] provides free amino acids and can be used for severe disease, selected high-risk presentations, or persisting symptoms with confirmed CMPA despite an adequate eHF trial. The course estimates eHF failure in fewer than 10%. Recheck adherence and alternative causes before escalating. Soy may be considered in selected older infants, while unmodified goat milk and lactose-free standard cow’s milk formula are inappropriate substitutes.
The course tests exclusive breastfeeding for the first six months [Pediatric Mid Q15] and complementary feeding around six months with ongoing breastfeeding [Pediatric Mid Q16]. Offer varied nutrient-dense foods with age-appropriate textures while excluding the confirmed culprit. Book I gives 6–12 months of therapeutic avoidance [Pediatric Mid Q17] as a common course figure, separate from the diagnostic trial. Reassess individual tolerance by phenotype, severity, testing and specialist advice. Its teaching estimates are around 50% tolerant by one year, >75% by three and 90% by six, with variable persistence.
Exam traps
Immediate multisystem symptoms suggest IgE. A well infant with a small amount of blood-streaked mucus can have FPIAP, after considering fissure and infection. Intense delayed vomiting with pallor points toward FPIES. Elimination without recurrence on appropriate reintroduction is weak evidence, particularly for common infant symptoms. “First-line formula” generally means eHF, while AAF follows severe disease or eHF failure.
Diagnostic and management pathways
- Immediate severe multisystem symptoms → emergency anaphylaxis care and allergy evaluation
- Stable infant with plausible delayed symptoms → assess growth and competing causes → short targeted elimination
- Improve → confirm by appropriate reintroduction or supervised challenge
- Confirmed formula-fed disease → eHF for most, AAF if severe or refractory → monitor growth and tolerance
Compare at a glance
| Mechanism | Timing and clues | Confirmation direction |
|---|---|---|
| IgE-mediated CMPA | Minutes to 2 hours, hives/wheeze/vomiting | History with targeted IgE testing and supervised challenge when needed |
| FPIAP | Small blood streaks or mucus in a well infant | Exclude alternatives and assess elimination/reintroduction response |
| FPIES | Delayed repetitive vomiting, pallor or lethargy | Specialist clinical assessment and supervised challenge when indicated |
| Lactose malabsorption | Gas and watery osmotic diarrhea without typical immediate allergy | Evaluate sugar malabsorption and context |
Short-answer practice
Describe the clinical presentation of IgE-mediated cow’s milk allergy.
Symptoms usually begin within minutes to two hours of milk exposure. Typical findings include urticaria or angioedema, vomiting, cough, wheeze or stridor. Multiple involved systems or circulatory compromise suggest anaphylaxis.
Supplementary clarification – not directly stated in the uploaded materials. Clinical references · ESPGHAN cow’s milk allergy position paper · WHO infant and young child feeding
Exam words
- immune-mediated reaction to milk proteins [Pediatric Mid Q1/Q7]
- casein and β-lactoglobulin [Pediatric Mid Q2/Q7]
- IgE-mediated allergy appears within minutes to about two hours [Pediatric Mid Q4 · Old p. 39 Q10]
- Non-IgE reactions are delayed [Pediatric Mid Q5–6]
- blood-streaked mucus in a generally well young infant [IRAT Q19 · Old p. 52 Q10]
- Cow’s Milk Related Symptom Score (CoMiSS) [Pediatric Mid Q8–10 · Formative Q3]
- Milk-specific serum IgE and skin prick testing [Pediatric Mid Q11]
- short diagnostic elimination followed by planned reintroduction or supervised oral food challenge [Old p. 52 Q10 · Book I pp. 267–269]
- extensively hydrolyzed formula (eHF) with proven efficacy [Pediatric Mid Q12 · Formative Q4 · IRAT Q13/Q19]
- Amino acid-based formula (AAF) [Pediatric Mid Q13–14 · Formative Q4]
- exclusive breastfeeding for the first six months [Pediatric Mid Q15]
- complementary feeding around six months with ongoing breastfeeding [Pediatric Mid Q16]
- 6–12 months of therapeutic avoidance [Pediatric Mid Q17]
Practice questions
Rapid revision sheet
Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.
- immune-mediated reaction to milk proteins [Pediatric Mid Q1/Q7]
- casein and β-lactoglobulin [Pediatric Mid Q2/Q7]
- IgE-mediated allergy appears within minutes to about two hours [Pediatric Mid Q4 · Old p. 39 Q10]
- Non-IgE reactions are delayed [Pediatric Mid Q5–6]
- blood-streaked mucus in a generally well young infant [IRAT Q19 · Old p. 52 Q10]
- Cow’s Milk Related Symptom Score (CoMiSS) [Pediatric Mid Q8–10 · Formative Q3]
Official College Textbook – Digestive Disorders – Part 1, pp. 267–269
Active recall
How does immediate IgE-mediated cow’s milk allergy differ from non-IgE disease?
Immediate reactions may include urticaria, wheeze or anaphylaxis. Delayed reactions are often gastrointestinal. An allergy-focused history guides testing or supervised elimination and reintroduction.
Official College Textbook – Digestive Disorders – Part 1, pp. 267–269
Recall the diagnostic and management pathway from memory.
Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.
- Immediate severe multisystem symptoms → emergency anaphylaxis care and allergy evaluation
- Stable infant with plausible delayed symptoms → assess growth and competing causes → short targeted elimination
- Improve → confirm by appropriate reintroduction or supervised challenge
- Confirmed formula-fed disease → eHF for most, AAF if severe or refractory → monitor growth and tolerance